Kiora Pharmaceuticals Inc SEC filings KPHMW
Kiora Pharmaceuticals Inc has 926 filings in SEC EDGAR's recent list, going back to Aug 9, 2006. Its latest annual report, Form ARS, was filed on May 1, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 7, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (material agreement, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | May 22, 2026 | — |
| CORRESP | Letter to the SEC | May 20, 2026 | — |
| UPLOAD | Letter from the SEC | May 20, 2026 | — |
| D | Filing | Apr 21, 2026 | — |
| EFFECT | Filing | Sep 19, 2025 | — |
| CORRESP | Letter to the SEC | Sep 17, 2025 | — |
| UPLOAD | Letter from the SEC | Sep 16, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 1, 2025 | — |
| CORRESP | Letter to the SEC | Jun 20, 2025 | — |
| UPLOAD | Letter from the SEC | Jun 10, 2025 | — |
| EFFECT | Filing | Mar 28, 2024 | — |
| CORRESP | Letter to the SEC | Mar 26, 2024 | — |
| UPLOAD | Letter from the SEC | Mar 4, 2024 | — |
| D | Filing | Feb 14, 2024 | — |
| EFFECT | Filing | Jun 1, 2023 | — |
| CORRESP | Letter to the SEC | May 31, 2023 | — |
| CORRESP | Letter to the SEC | May 31, 2023 | — |
| CORRESP | Letter to the SEC | May 24, 2023 | — |
| CORRESP | Letter to the SEC | May 24, 2023 | — |
| CORRESP | Letter to the SEC | May 23, 2023 | — |
| UPLOAD | Letter from the SEC | May 9, 2023 | — |
| D | Filing | Feb 17, 2023 | — |
| D | Filing | Feb 17, 2023 | — |
| EFFECT | Filing | Feb 13, 2023 | — |
| CORRESP | Letter to the SEC | Feb 9, 2023 | — |
| UPLOAD | Letter from the SEC | Feb 9, 2023 | — |
| EFFECT | Filing | Dec 28, 2022 | — |
| CORRESP | Letter to the SEC | Dec 23, 2022 | — |
| UPLOAD | Letter from the SEC | Dec 23, 2022 | — |
| EFFECT | Filing | Jul 21, 2022 | — |
| CORRESP | Letter to the SEC | Jul 21, 2022 | — |
| CORRESP | Letter to the SEC | Jul 19, 2022 | — |
| NT 10-Q | Filing | May 17, 2022 | Mar 31, 2022 |
| UPLOAD | Letter from the SEC | May 9, 2022 | — |
| NT 10-K | Form nt 10-k | Mar 31, 2022 | Dec 31, 2021 |
| D | Filing | Nov 4, 2021 | — |
| D | Filing | Aug 23, 2021 | — |
| EFFECT | Filing | Apr 30, 2021 | — |
| CORRESP | Letter to the SEC | Apr 28, 2021 | — |
| UPLOAD | Letter from the SEC | Apr 21, 2021 | — |
| D | Filing | Jan 21, 2021 | — |
| D | Filing | Jan 4, 2021 | — |
| 25-NSE | Delisting notice | Aug 5, 2020 | — |
| D | Filing | Jan 15, 2020 | — |
| EFFECT | Filing | Nov 18, 2019 | — |
| CORRESP | Letter to the SEC | Nov 14, 2019 | — |
| CORRESP | Letter to the SEC | Nov 8, 2019 | — |
| UPLOAD | Letter from the SEC | Oct 31, 2019 | — |
| D | Filing | Oct 8, 2019 | — |
| EFFECT | Filing | May 13, 2019 | — |
| CORRESP | Letter to the SEC | May 9, 2019 | — |
| UPLOAD | Letter from the SEC | May 9, 2019 | — |
| CT ORDER | Filing | Oct 24, 2018 | — |
| POS EX | Filing | Apr 13, 2018 | — |
| EFFECT | Filing | Apr 12, 2018 | — |
| CORRESP | Letter to the SEC | Apr 10, 2018 | — |
| CORRESP | Letter to the SEC | Apr 10, 2018 | — |
| CORRESP | Letter to the SEC | Apr 9, 2018 | — |
| UPLOAD | Letter from the SEC | Apr 3, 2018 | — |
| POS EX | Filing | Jun 9, 2017 | — |
| EFFECT | Filing | Jun 8, 2017 | — |
| CORRESP | Letter to the SEC | Jun 6, 2017 | — |
| CORRESP | Letter to the SEC | Jun 6, 2017 | — |
| CORRESP | Letter to the SEC | May 5, 2017 | — |
| CT ORDER | Filing | Mar 22, 2017 | — |
| RW | Filing | Oct 31, 2016 | — |
| D | Filing | Jul 7, 2016 | — |
| EFFECT | Filing | May 6, 2016 | — |
| CORRESP | Letter to the SEC | May 4, 2016 | — |
| CORRESP | Letter to the SEC | Apr 15, 2016 | — |
| UPLOAD | Letter from the SEC | Apr 7, 2016 | — |
| D | Filing | Mar 21, 2016 | — |
| CERTNAS | Auto-generated paper document | Jul 30, 2015 | — |
| EFFECT | Filing | Jul 30, 2015 | — |
| 8-A12B/A | Filing | Jul 30, 2015 | — |
| CERTNAS | Auto-generated paper document | Jul 28, 2015 | — |
| CT ORDER | Filing | Jul 28, 2015 | — |
| 8-A12B | Filing | Jul 28, 2015 | — |
| CORRESP | Letter to the SEC | Jul 24, 2015 | — |
| CORRESP | Letter to the SEC | Jul 24, 2015 | — |
| UPLOAD | Letter from the SEC | Jun 17, 2015 | — |
| CERTNAS | Auto-generated paper document | Apr 28, 2015 | — |
| CT ORDER | Filing | Feb 19, 2015 | — |
| EFFECT | Filing | Feb 12, 2015 | — |
| CORRESP | Letter to the SEC | Feb 10, 2015 | — |
| CORRESP | Letter to the SEC | Feb 10, 2015 | — |
| 8-A12G | Filing | Feb 5, 2015 | — |
| CORRESP | Letter to the SEC | Jan 23, 2015 | — |
| CORRESP | Letter to the SEC | Jan 23, 2015 | — |
| CORRESP | Letter to the SEC | Dec 1, 2014 | — |
| UPLOAD | Letter from the SEC | Nov 26, 2014 | — |
| CORRESP | Letter to the SEC | Oct 2, 2014 | — |
| CORRESP | Letter to the SEC | Oct 2, 2014 | — |
| CERTNAS | Auto-generated paper document | Oct 1, 2014 | — |
| 8-A12B | Filing | Sep 30, 2014 | — |
| CORRESP | Letter to the SEC | Sep 30, 2014 | — |
| CORRESP | Letter to the SEC | Sep 30, 2014 | — |
| CORRESP | Letter to the SEC | Sep 26, 2014 | — |
| UPLOAD | Letter from the SEC | Sep 24, 2014 | — |
| CORRESP | Letter to the SEC | Sep 12, 2014 | — |
| UPLOAD | Letter from the SEC | Sep 9, 2014 | — |
| CORRESP | Letter to the SEC | Aug 8, 2014 | — |
| UPLOAD | Letter from the SEC | Aug 5, 2014 | — |
| CORRESP | Letter to the SEC | Jul 30, 2014 | — |
| D | Filing | Jul 24, 2014 | — |
| UPLOAD | Letter from the SEC | Jul 16, 2014 | — |
| UPLOAD | Letter from the SEC | Jul 15, 2014 | — |
| DRS/A | Filing | Jul 8, 2014 | — |
| DRSLTR | Filing | Jul 7, 2014 | — |
| UPLOAD | Letter from the SEC | Jun 12, 2014 | — |
| DRS | Filing | May 14, 2014 | — |
| D | Filing | Sep 26, 2013 | — |
| D | Filing | Jan 5, 2011 | — |
| D | Filing | Dec 21, 2009 | — |
| D | Filing | Nov 13, 2009 | — |
| REGDEX | Auto-generated paper document | Feb 4, 2009 | — |
| REGDEX | Auto-generated paper document | Apr 2, 2008 | — |
| REGDEX | Auto-generated paper document | Jan 26, 2007 | — |
| REGDEX | Auto-generated paper document | Aug 9, 2006 | — |
Showing 119 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- KPRX (Nasdaq), KPHMW (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Encinitas, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1372514
- Former names
- EYEGATE PHARMACEUTICALS INC (until Nov 4, 2021)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.